AudioEye and Acumen Pharmaceuticals to report third-quarter 2026 results
AudioEye (AEYE) reports on October 26 after the close, Acumen Pharmaceuticals (ABOS) before the open. TradingView publishes consensus revenue and EPS estimates from FactSet.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
AudioEye, Inc. (AEYE) is scheduled to publish its results for the third quarter of 2026 on October 26, after the market closes. The release is expected at 4:01 PM ET (8:01 PM UTC). Analysts' consensus points to revenue of 10.94 million USD and earnings per share of 0.27 USD, according to TradingView, which cites FactSet data.
Acumen Pharmaceuticals (ABOS) will report on the same day, October 26, before the market opens at 7:00 AM ET (11:00 AM UTC). The consensus expects no revenue and a loss of 0.39 USD per share. As with AudioEye, the figures come from TradingView and originate with FactSet.
why it matters
Both companies are small, so the reports are unlikely to move the broader market. For investors in these stocks, the actual results compared with the estimates matter most, and AudioEye has beaten EPS forecasts in recent quarters.
tags
instruments
sources
- AEYE Q3'26 Earnings: EPS estimate is 0.27 USD — TradingView, 23 October 2026 at 11:00 UTC
- ABOS Q3'26 Earnings: EPS estimate is (0.39) USD — TradingView, 23 October 2026 at 11:00 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗